Stay updated on Mirvetuximab Soravtansine Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Soravtansine Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T12:58:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2; the page otherwise remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-19T13:43:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:58.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access to the study record is blocked. The standard site header and footer remain visible, but the study content is not accessible.
    Difference
    20%
    Check dated 2026-09-21T22:01:14.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a minor update to the page or platform. No study content or public information is altered.
    Difference
    0.1%
    Check dated 2026-08-31T17:49:19.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page displays a new Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor metadata or content update that does not alter the study details.
    Difference
    0.0%
    Check dated 2026-08-10T10:31:25.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Soravtansine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.